Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

CLLS

Cellectis (CLLS)

Cellectis SA

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CLLS

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
06/28/2024	4:30PM	GlobeNewswire Inc.	Cellectis Reports Results from Shareholders Meeting Held on June 28, 2024	NASDAQ:CLLS	Cellectis SA
06/20/2024	4:30PM	GlobeNewswire Inc.	Cellectis Publishes a Scientific Article Unveiling Three Key Factors for Efficient TALE Base Editing	NASDAQ:CLLS	Cellectis SA
06/12/2024	4:35PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CLLS	Cellectis SA
06/12/2024	4:30PM	GlobeNewswire Inc.	Cellectis Unveils a Non-Viral Gene Therapy Approach for Sickle Cell Disease in Nature Communications	NASDAQ:CLLS	Cellectis SA
06/04/2024	4:41PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CLLS	Cellectis SA
06/04/2024	4:30PM	GlobeNewswire Inc.	Cellectis Receives Orphan Drug Designation for UCART22, its Allogeneic CAR T Product for Patients with Acute Lymphoblastic Leukemia	NASDAQ:CLLS	Cellectis SA
05/29/2024	4:35PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CLLS	Cellectis SA
05/29/2024	4:30PM	GlobeNewswire Inc.	Cellectis’ Annual Shareholders General Meeting to be Held on June 28, 2024	NASDAQ:CLLS	Cellectis SA
05/28/2024	4:30PM	GlobeNewswire Inc.	Cellectis Reports Financial Results for First Quarter 2024	NASDAQ:CLLS	Cellectis SA
05/28/2024	6:00AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CLLS	Cellectis SA
05/27/2024	4:30PM	GlobeNewswire Inc.	Cellectis to Report First Quarter 2024 Financial Results on May 28, 2024	NASDAQ:CLLS	Cellectis SA
05/24/2024	4:06PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CLLS	Cellectis SA
05/06/2024	6:00AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CLLS	Cellectis SA
05/06/2024	2:00AM	GlobeNewswire Inc.	Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca	NASDAQ:CLLS	Cellectis SA
05/02/2024	4:30PM	GlobeNewswire Inc.	Cellectis Appoints Arthur Stril as Interim Chief Financial Officer	NASDAQ:CLLS	Cellectis SA
04/29/2024	4:46PM	GlobeNewswire Inc.	Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023	NASDAQ:CLLS	Cellectis SA
04/22/2024	4:30PM	GlobeNewswire Inc.	Cellectis Presents Novel TALEN® Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs	NASDAQ:CLLS	Cellectis SA
04/10/2024	4:30PM	GlobeNewswire Inc.	Cellectis Publishes a Novel Intronic Gene Editing Approach For the Treatment of Inborn Metabolic Diseases by Edited HSPCs	NASDAQ:CLLS	Cellectis SA
04/08/2024	4:30PM	GlobeNewswire Inc.	Cellectis Announces Two Poster Presentations on Novel TALEN® Editing Process for Gene Correction and Gene Insertion in HSPCs at the ASGCT Annual Meeting	NASDAQ:CLLS	Cellectis SA
01/16/2024	4:45PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CLLS	Cellectis SA
01/16/2024	4:30PM	GlobeNewswire Inc.	Cellectis announces the drawdown of the second tranche of €15 million under the credit facility agreement entered with the European Investment Bank (EIB)	NASDAQ:CLLS	Cellectis SA
12/22/2023	4:35PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CLLS	Cellectis SA
12/22/2023	4:30PM	GlobeNewswire Inc.	Cellectis Reports Results from Shareholders Meeting Held on December 22, 2023	NASDAQ:CLLS	Cellectis SA
12/22/2023	4:01PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CLLS	Cellectis SA
12/05/2023	4:01PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CLLS	Cellectis SA
11/17/2023	4:56PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CLLS	Cellectis SA
11/17/2023	4:35PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CLLS	Cellectis SA
11/17/2023	4:30PM	GlobeNewswire Inc.	Cellectis’ Shareholders Meeting to be Held on December 22, 2023	NASDAQ:CLLS	Cellectis SA
11/15/2023	7:48AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CLLS	Cellectis SA
11/15/2023	2:30AM	GlobeNewswire Inc.	Cellectis Announces the execution of the Subsequent Investment Agreement with AstraZeneca	NASDAQ:CLLS	Cellectis SA

Showing the most relevant articles for your search:NASDAQ:CLLS

1 2 3 4 5 6 7 8 9 10 Next >>

Northwest Biotherapeutics (QB)

Ethema Health (PK)

1812 Brewing (PK)

Kraig Biocraft Laborator... (QB)

ERHC Energy (CE)

Anavex Life Sciences

Faraday Future Intellige...

Branded Legacy (PK)

Bioelectronics (PK)

Fannie Mae (QB)

Global Developments (PK)

Asia Broadband (PK)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions